Difference between revisions of "NM Coordinating Committee"
Jump to navigation
Jump to search
m |
m |
||
| (12 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
| − | + | Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD | |
| − | + | <br />RSNA Staff Support: Julie Lisiecki | |
| − | [https://tinyurl.com/QIBA-NM-CC-Roster Roster] | + | *[https://tinyurl.com/QIBA-NM-CC-Roster '''Roster'''] |
==Scope== | ==Scope== | ||
| − | The NM Coordinating Committee | + | The NM Coordinating Committee is responsible for: |
| + | :* Monitoring and coordinating the activities of NM Biomarker Committees | ||
| + | ::* [https://docs.google.com/spreadsheets/d/1A7_uieyw0uu2DKbP6Vkzd37JuBEb2zmm-yqfXJtV-p4/edit?usp=sharing QIBA Profile Dashboard] (NM Page) | ||
:* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]] | :* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]] | ||
:* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee | :* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee | ||
:* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees | :* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees | ||
| − | ::* [[FDG-PET_Biomarker_Ctte]] | + | ::*[[FDG-PET_Biomarker_Ctte]] |
::* [[PET_Amyloid_Biomarker_Ctte]] | ::* [[PET_Amyloid_Biomarker_Ctte]] | ||
::* [[SPECT_Biomarker_Ctte]] | ::* [[SPECT_Biomarker_Ctte]] | ||
| − | ::* TC99m Biomarker Committee [page | + | ::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee] |
| − | ::* I-123 Biomarker Committee [page | + | ::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee] |
| + | ::* PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee] | ||
| + | |||
==Meetings== | ==Meetings== | ||
| − | * | + | * Zoom calls are held Quarterly. Please contact RSNA Staff for details. |
Revision as of 22:59, 17 May 2022
Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
RSNA Staff Support: Julie Lisiecki
Scope
The NM Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of NM Biomarker Committees
- QIBA Profile Dashboard (NM Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
- I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
- PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]
Meetings
- Zoom calls are held Quarterly. Please contact RSNA Staff for details.